Data from a small, early-stage safety trial testing Moderna Inc's experimental COVID-19 vaccine does not provide the critical data needed to assess its effectiveness, health-focused Stat News reported on Tuesday, citing experts.
Moderna said on Monday the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers.
Moderna later announced a stock sale that could raise about $1.5 billion, sending shares lower early on Tuesday. - lack of information about the ages of the eight subjects whose antibodies were analyzed, an important question given the virus is particularly lethal to older people
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna Says Initial Covid-19 Vaccine Results Are PositiveModerna said human subjects in a Phase 1 trial of a candidate Covid-19 vaccine produced immune responses that were a positive sign of the vaccine’s potential to prevent infection with the new coronavirus
Weiterlesen »
Stéphane Bancel, CEO of Moderna, the biotech making a COVID-19 vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »
Vaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccineHeavy hearts soared Monday with news that Moderna's Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects.
Weiterlesen »
Early data on Moderna's COVID-19 vaccine insufficient: Stat NewsData from a small, early-stage safety trial testing Moderna Inc's experimental COVID-19 vaccine does not provide critical data to assess its effectiveness, Stat News reported on Tuesday, citing experts.
Weiterlesen »
Amanda Kloots Celebrates a 'Small Win' Amid Husband's COVID-19 FightNick Cordero is continuing to fight the coronavirus in the hospital.
Weiterlesen »